Education
About Us
Working with TipRanks
Follow Us
Bio-Techne (TECH)
NASDAQ:TECH
Total Valuation
Bio-Techne has a market cap or net worth of $8.08B. The enterprise value is $13.10B.
Market Cap$8.08B
Enterprise Value$13.10B
Share Statistics
Bio-Techne has 156,767,290 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding156,767,290
Owned by Insiders0.23%
Owned by Institutions28.48%
Financial Efficiency
Bio-Techne’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 7.28%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)7.28%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee373.89K
Profits Per Employee54.22K
Employee Count3,100
Asset Turnover0.43
Inventory Turnover2.17
Valuation Ratios
The current PE Ratio of Bio-Techne is 67.18. Bio-Techne’s PEG ratio is 9.73.
PE Ratio67.18
PS Ratio0.00
PB Ratio6.52
Price to Fair Value5.46
Price to FCF59.36
Price to Operating Cash Flow50.44
PEG Ratio9.73
Income Statement
In the last 12 months, Bio-Techne had revenue of 1.16B and earned 168.10M in profits. Earnings per share was 1.07.
Revenue1.16B
Gross Profit769.73M
Operating Income206.69M
Pretax Income185.69M
Net Income168.10M
EBITDA310.37M
Earnings Per Share (EPS)1.07
Cash Flow
In the last 12 months, operating cash flow was 264.85M and capital expenditures -44.10M, giving a free cash flow of 220.75M billion.
Operating Cash Flow264.85M
Free Cash Flow220.75M
Free Cash Flow per Share1.41
Dividends & Yields
Bio-Techne pays an annual dividend of $0.316, resulting in a dividend yield of 0.62%
Dividend Per Share$0.316
Dividend Yield0.62%
Payout Ratio16.72%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.93
52-Week Price Change-33.09%
50-Day Moving Average49.77
200-Day Moving Average65.67
Relative Strength Index (RSI)52.73
Average Volume (3m)2.60M
Important Dates
Bio-Techne upcoming earnings date is Aug 12, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateAug 12, 2025
Ex-Dividend DateMay 19, 2025
Financial Position
Bio-Techne as a current ratio of 3.87, with Debt / Equity ratio of 23.14%
Current Ratio3.87
Quick Ratio2.75
Debt to Market Cap0.03
Net Debt to EBITDA0.86
Interest Coverage Ratio13.13
Taxes
In the past 12 months, Bio-Techne has paid 17.58M in taxes.
Income Tax17.58M
Effective Tax Rate0.09
Enterprise Valuation
Bio-Techne EV to EBITDA ratio is 37.25, with an EV/FCF ratio of 48.97.
EV to Sales9.97
EV to EBITDA37.25
EV to Free Cash Flow48.97
EV to Operating Cash Flow38.67
Balance Sheet
Bio-Techne has $140.67M in cash and marketable securities with $423.50M in debt, giving a net cash position of $282.83M billion.
Cash & Marketable Securities$140.67M
Total Debt$423.50M
Net Cash$282.83M
Net Cash Per Share$1.80
Tangible Book Value Per Share$3.74
Margins
Gross margin is 67.72%, with operating margin of 17.83%, and net profit margin of 14.50%.
Gross Margin67.72%
Operating Margin17.83%
Pretax Margin16.02%
Net Profit Margin14.50%
EBITDA Margin26.78%
EBIT Margin17.38%
Analyst Forecast
The average price target for Bio-Techne is $68.80, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$68.80
Price Target Upside36.18% Upside
Analyst ConsensusModerate Buy
Analyst Count11
Revenue Growth Forecast4.72%
EPS Growth Forecast-35.33%